Jeffrey Rathmell

May 10, 2018

Grant bolsters kidney cancer immunotherapy research

W. Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt-Ingram Cancer Center (VICC), has received a grant to research the role of immunosuppression in the tumor microenvironment for kidney cancer.

By Doug Campbell
November 10, 2016

Links between immune cells and metabolism explored

At the intersection of immunology and metabolism is a burgeoning new field: immunometabolism. It’s an area where Vanderbilt has exceptional strengths, said Jeffrey Rathmell, Ph.D., Cornelius Vanderbilt Professor of Immunobiology.

By Leigh MacMillan
September 28, 2016

Celebration honors nine endowed chair recipients

Nine faculty members who hold endowed chairs were honored and donors were thanked during a festive celebration Sept. 26 at the Student Life Center.

By VUMC News and Communications
September 14, 2016

Restore T cells to fight leukemia

Modulation of T cell metabolism thus may represent a new therapeutic avenue for leukemia patients.

By Bill Snyder
May 19, 2016

VICC investigators in spotlight at AACR conference

A top Vanderbilt-Ingram Cancer Center (VICC) investigator recently met with Vice President Joe Biden regarding the National Cancer Moonshot Initiative, a major national program to identify, fund and accelerate the most promising research leading to cancer cures.

By VUMC News and Communications
August 20, 2015

Rathmell to lead new Center for Immunobiology

Jeffrey Rathmell, Ph.D., has been recruited to Vanderbilt University Medical Center (VUMC) to lead a new Center for Immunobiology, a structure supported by the Department of Pathology, Microbiology and Immunology, the Department of Medicine and Vanderbilt-Ingram Cancer Center (VICC).

By VUMC News and Communications
1 2